CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes

被引:216
作者
Bahadur, N
Leathart, JBS
Mutch, E
Steimel-Crespi, D
Dunn, SA
Gilissen, R
Van Houdt, J
Hendrickx, J
Mannens, G
Bohets, H
Williams, FM
Armstrong, M
Crespi, CL
Daly, AK
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Dept Pharmacol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Med, Dept Environm & Occupat Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Gentest Corp, Woburn, MA 01801 USA
[4] Janssen Res Fdn, Janssen Pharmaceut, B-2340 Beerse, Belgium
关键词
cytochrome P450; CYP2C8; polymorphism; paclitaxel; human; liver;
D O I
10.1016/S0006-2952(02)01354-0
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Published cDNA sequences suggest the existence of non-synonymous single nucleotide polymorphisms in the cytochrome P450 CYP2C8. To determine whether these polymorphisms could be confirmed in a Caucasian population and to investigate whether additional polymorphisms occur in the coding and upstream regions of this gene, we screened for previously described and for novel polymorphisms using PCR-RFLP and SSCP analysis. We confirmed the existence of two of the previously detected polymorphisms which give rise to the amino acid substitutions I264M and K399R, respectively, but failed to detect three others in our population. We also confirmed that a recently identified polymorphism (R139K) is linked to K399R (CYP2C8*3) in our study population. The allele frequencies for the I264M (CYP2C8*4 allele) and the CYP2C8*3 allele were 0.075 and 0.15, respectively. Three novel polymorphisms (T-370G, C-271A and T1196C/L390S) were also detected with the upstream polymorphisms showing allele frequencies of 0.061 and 0.196, respectively, but the L390S polymorphism detected only in a single subject. An additional single subject was heterozygous for a polymorphism recently described in African-Americans (A805T; CYP2C8*2 allele). The functional significance of the two upstream polymorphisms and the CYP2C8*3 and CYP2C8*4 alleles was investigated in human liver microsomes. Samples heterozygous for CYP2C8*3 showed significantly lower paclitaxel 6alpha-hydroxylase activity compared with wild-type samples. Median activity associated with CYP2C8*4 also appeared lower than the wild-type but the difference was not significant. There was no evidence that either upstream polymorphism gave rise to altered CYP2C8 expression. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1579 / 1589
页数:11
相关论文
共 46 条
[1]
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]
Baldwin SJ, 1999, BRIT J CLIN PHARMACO, V48, P424
[3]
FAST AND SENSITIVE SILVER STAINING OF DNA IN POLYACRYLAMIDE GELS [J].
BASSAM, BJ ;
CAETANOANOLLES, G ;
GRESSHOFF, PM .
ANALYTICAL BIOCHEMISTRY, 1991, 196 (01) :80-83
[4]
GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES [J].
BLIN, N ;
STAFFORD, DW .
NUCLEIC ACIDS RESEARCH, 1976, 3 (09) :2303-2308
[5]
Antisense oligonucleotides against cytochrome P4502C8 attenuate EDHF-mediated Ca2+ changes and dilation in isolated resistance arteries [J].
Bolz, SS ;
Fisslthaler, B ;
Pieperhoff, S ;
De Wit, C ;
Fleming, I ;
Busse, R ;
Pohl, U .
FASEB JOURNAL, 2000, 14 (02) :255-260
[6]
Busse D, 1995, N-S ARCH PHARMACOL, V353, P116
[7]
CRESTEIL T, 1994, CANCER RES, V275, P566
[8]
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid [J].
Dai, D ;
Zeldin, DC ;
Blaisdell, JA ;
Chanas, B ;
Coulter, SJ ;
Ghanayem, BI ;
Goldstein, JA .
PHARMACOGENETICS, 2001, 11 (07) :597-607
[9]
CYP2D6 multiallelism [J].
Daly, AK ;
Steen, VM ;
Fairbrother, KS ;
Idle, JR .
CYTOCHROME P450, PT B, 1996, 272 :199-210
[10]
GENETIC AND METABOLIC CRITERIA FOR THE ASSIGNMENT OF DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P4502D6) PHENOTYPES [J].
DALY, AK ;
ARMSTRONG, M ;
MONKMAN, SC ;
IDLE, ME ;
IDLE, JR .
PHARMACOGENETICS, 1991, 1 (01) :33-41